View Older Stories

Oct 29, 2018 07:52AM Roth Capital Upgrades Ligand Pharma (LGND) to Buy

Aug 8, 2018 05:18AM Roth Capital Downgrades Ligand Pharma (LGND) to Neutral Citing Valuation

May 9, 2018 08:15AM Ligand Pharma (LGND) PT Raised to $172 at Roth Capital

Apr 6, 2018 08:40AM Roth Capital Reiterates Buy on Ligand Pharma (LGND)

Nov 21, 2016 06:42AM Roth Capital Affirms Ligand Pharma (LGND) at 'Buy' Following Presentation of New Phase 2 DUET Data (RTRX)

Sep 27, 2016 10:15AM Roth Capital Trims PT on Ligand Pharma (LGND) to $150 Amid New Kyprolis Data (AMGN)

Sep 13, 2016 12:29PM Roth Capital Affirms Ligand Pharma (LGND) at 'Buy' Following Initiation of LGD-6972 Phase 2 in T2D

Sep 7, 2016 12:04PM Streetinsider.com's Hot Lunchtime Reads 9/7: (AMD) (LGND) (EXPR) (GILD)

Sep 7, 2016 11:00AM Roth Capital Bumps PT on Ligand Pharma (LGND) up to $151 Following Sparsentan Data; Affirms at 'Buy'

Sep 7, 2016 06:53AM Roth Capital Positive on Ligand Pharma (LGND) Ahead of Sept. Catalysts; Affirms at 'Buy'

Aug 5, 2016 12:12PM Streetinsider.com's Hot Lunchtime Reads 8/5: (MU) (MRK) (LGND) (FIVE)

Aug 5, 2016 11:27AM Roth Capital Says to Buy Ligand Pharma (LGND) on Today's 'Bad' Downgrade

Aug 4, 2016 02:27PM Roth Capital Bumps PT on Ligand Pharma (LGND) up to $149; Says Running on All Cylinders

Jul 19, 2016 10:21AM Roth Capital Affirms Ligand Pharma (LGND) Following Solid Q2 Revenue Results for Promacta (NVS)

Jul 12, 2016 08:37AM Roth Affirms Ligand Pharma (LGND) at 'Buy' Following Strong Severe PPD Data from SAGE Therapeutics (SAGE)

Jul 8, 2016 09:47AM Roth Positive on Ligand Pharma (LGND) Amid Another Key OmniAb Collaboration (GILD)

Jul 5, 2016 09:18AM Roth Keeps Ligand Pharma (LGND) at 'Buy' as Kyprolis Receives Expanded Indication in Europe (AMGN)

May 12, 2016 12:22PM Streetinsider.com's Hot Lunchtime Reads 5/12: (AAPL) (BA) (LVLT) (JCP)

May 12, 2016 12:01PM Roth Capital Affirms Ligand Pharma (LGND) at 'Buy' as Baxdela Phase 3 Met Primary Endpoints

Apr 22, 2016 02:23PM Roth Affirms Ligand Pharma (LGND) at 'Buy' Following FDA Acceptance of Lundbeck's CE-Carbamazepine NDA Resubmission

Apr 20, 2016 12:37PM Orphan Drug Exclusivity for Spectrum's (SPPI) Evomela is Important Increment for Ligand (LGND) - Roth Capital

Apr 7, 2016 07:56AM Roth Remains Bullish on Ligand Pharma (LGND) as Revolade Gets Expanded Approval in Europe (NVS)

Mar 11, 2016 09:29AM Roth Bumps PT on Ligand Pharma (LGND) up to $147 Following Evomela Approval

Jan 22, 2016 07:25AM Roth Reiterates Ligand Pharma (LGND) at 'Buy' Following Additional Kyprolis Approval

Jan 13, 2016 12:23PM Streetinsider.com's Hot Lunchtime Reads 1/13: (ESRX) (MSFT) (AAPL) (LGND)

Jan 13, 2016 11:56AM Roth Capital Impressed by Speed of Ligand (LGND) Capitalizing on OMT Acquisition; Affirms at 'Buy'

Dec 31, 2015 09:58AM Roth Capital Remains Bullish Following Ligand Pharma's (LGND) Supply Agreement with Gilead (GILD)

Dec 18, 2015 08:22AM Roth Positive on Ligand's (LGND) Move to Acquire OMT; Bumps PT to $146

Nov 25, 2015 11:06AM New PDUFA Date, Licensing Agreement Bode Well for Ligand Pharma (LGND); Roth Affirms at 'Buy'

Nov 19, 2015 07:13AM Ligand Pharma (LGND) Provides Updates at Analyst Day; Roth Capital Raises Price Target to $144

Oct 23, 2015 10:09AM Ligand Pharma (LGND) Announces FDA CRL for Evomela's NDA; Roth Capital Reiterates Buy

Oct 23, 2015 09:18AM Roth Capital Trims PT on Ligand (LGND) to $138; Will Remove Evomela from Revenue Projections (SPPI)

Sep 30, 2015 08:02AM Roth Capital Raises Price Target on Ligand Pharma (LGND) Ahead of 3Q Results

Sep 2, 2015 09:05AM Roth Capital Reiterates Buy on Ligand Pharma (LGND) Following E.U. Approval of Promacta

Sep 2, 2015 08:38AM Ligand Pharma (LGND) Reaffirmed at 'Buy' by Roth Following European Promacta Approval, Evomela Update

Aug 25, 2015 09:28AM Roth Capital Highlights Biotech Picks 'for the Turn' and Over the Long Haul (PTN) (LGND) (TGTX) (CLDX)

Aug 24, 2015 12:02PM Streetinsider.com's Hot Lunchtime Reads 8/24: (AAPL) (LGND) (MON) (FCAU)

Aug 24, 2015 11:51AM Roth Capital Affirms Ligand Pharma (LGND) at 'Buy' Following Expanded Promacta Indication

Jul 29, 2015 03:01PM Ligand Pharma (LGND) Becomes 'Value Play' as Viking (VKTX) Advances VK2809 - Roth Capital

Jul 24, 2015 02:01PM Roth Capital Remains Bullish on Ligand Pharma (LGND) Following FDA Approval of Kyprolis sNDA (AMGN)

Jul 21, 2015 09:00AM Roth Affirms Ligand Pharma (LGND) at 'Buy'; Promacta Q2 Revenue Outpaces Expectations (NVS)

Jun 12, 2015 08:40AM Promacta Receives FDA Approval for Children with ITP; Roth Raffirms Ligan Pharma (LGND) at 'Buy' (NVS)

Jun 8, 2015 09:31AM Roth Capital 'Impressed' with '6972 Safety Profile; Affirms Ligand Pharma (LGND) at 'Buy'

Jun 5, 2015 08:40AM Roth Capital Raised Price Target Following Ligand Pharma (LGND) Receipt of Milestone Payment

May 14, 2015 10:19AM Roth Capital Affirms Ligand Pharma (LGND) Following Positive SAGE-547 Update (SAGE)

May 11, 2015 12:12PM Streetinsider.com's Hot Lunchtime Reads 5/11: (LGND) (AAPL) (RL) (JPM) (OIL)

May 11, 2015 11:34AM Ligand Pharma (LGND) PT Lifted to $127 at Roth Capital Following Q1 and as Pipeline Expands

Mar 30, 2015 10:41AM Roth Affirms Ligand (LGND) at 'Buy' Following Amgen (AMGN), Spectrum (SPPI) Updates

Mar 2, 2015 02:24PM Roth Capital Positive on Ligand Pharma (LGND); Kyprolis Met Primary Endpoint in ENDEAVOR Trial (AMGN)

Feb 3, 2015 10:18AM Ligand's (LGND) License with Sermonix Demonstrates Great Example of Core Business Model - Roth Capital

View Older Stories